Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Part of paid clinical trials in Seattle, Washington.

Sponsor
University of Washington
Study ID
NCT06270641
Status
Recruiting
Apply to this trial

Conditions

  • Fatigue
  • Multiple Sclerosis (MS)
  • Physical Inactivity

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • ExerciseRx intervention — OTHER
    ExerciseRx is a cloud-based, HIPPA-compliant free software platform created for healthcare providers to prescribe and monitor physical activity as part of routine care. ExerciseRx translates clinically relevant activity data collected by the patient's existing personal smart devices (Android or iOS phone) into actionable metrics on a dashboard within the Epic electronic health record. Providers then use the platform to prescribe physical activity tailored to patients' ability levels and preferences. The platform incorporates behavior change strategies, including motivational feedback and nudges. It also facilitates a feedback loop with the provider, fostering caring patient-provider connections around activity promotion and behavior change. ExerciseRx leverages patients' personal smartphone capabilities to track, quantify, and tailor personalized physical activity solutions, which makes it more readily scalable as a solution across diverse patient populations.

Study Details

This study aims to advance the scientific understanding and potential future implementation of physical activity promotion by testing the efficacy of a phone-based app for increasing activity in insufficiently active patients with multiple sclerosis (MS).

Key Dates

Start date
Feb 16, 2024
Status verified
Feb 2024
Primary completion
Apr 30, 2025
Completion
Sep 30, 2026

Study Design

Enrollment
106 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention ExerciseRx-MS
    Participants use the ExerciseRx app to meet personalized daily step targets and weekly goals. They will receive MS Exercise and Physical Activity Recommendations and complete in-app surveys about barriers to being active and physical activity level. The ExerciseRx app will adjust the personalized step count goals based on percentage met of the previous week goal and providers will send supportive messages based on participant activity. Participants will complete validated self-report assessments. Providers may also provide participants with additional guidance, make referrals, or schedule telemedicine or in-person clinic follow ups if needed to support the participant's physical activity progression.
  • No Intervention: Usual care
    Participants receive MS Exercise and Physical Activity Recommendations, will continue typical physical activity, and complete validated self-report assessments. At the end of 26 weeks, staff will offer the participants the ExerciseRx intervention protocol.

Primary Outcome Measure

Physical activity: daily average step count [ Time Frame: Baseline and week 13 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UW MedicineSeattleWashington98133
Laurie Kavanagh, MPH
[email protected]
206-668-4168

Find similar trials in Seattle, WA

By research site
UW Medicine· Seattle, WA

Related Studies